Skip to content

Study note

Prediction of mortality in intensive care unit with short-term heart rate variability: Machine learning-based analysis of the MIMIC-III database.

PMID 39778237 (2025): heart rate variability, hrv — Recovery speed (study note for endurance athletes).

Updated Jul 22, 2026

Read the study note

Study note • PMID 39778237

Prediction of mortality in intensive care unit with short-term heart rate variability: Machine learning-based analysis of the MIMIC-III database.

Computers in biology and medicine2025 • DOI 10.1016/j.compbiomed.2024.109635

How to use this page

This note summarizes one study record. Check the participants, methods, results, and limitations before applying it to training.

  • Design signal: controlled study.
  • Population relevance: mixed/unclear athlete specificity.
  • Consistency: single-study evidence.
  • Practical recommendation depends on tolerance, context, and whether it protects training consistency.

ELI5

In plain language

BACKGROUND: Prognosis prediction in the intensive care unit (ICU) traditionally relied on physiological scoring systems based on clinical indicators at admission. (controlled study; participants).

The abstract suggests a positive effect on Recovery speed under the tested conditions. Treat this as a signal, not a guarantee; confirm methods and context in the full paper.

Takeaways

What the abstract suggests

  • Study question: BACKGROUND: Prognosis prediction in the intensive care unit (ICU) traditionally relied on physiological scoring systems based on clinical indicators at admission.
  • The abstract suggests a positive effect on Recovery speed under the tested conditions.
  • Population: participants.
  • Protocol cues (title/abstract): 0.5h.

Protocol

Protocol (as reported)

  • Intervention/exposure: heart rate variability, hrv (vs comparison group).
  • Dose/time/duration cues in abstract/title: 0.5h.
  • Outcomes: Recovery speed.
  • Replication note: abstracts often omit adherence and timing; confirm details before changing training or supplementation.

Fit

Who it may help, and who should be cautious

Who it helps

  • Athletes similar to the study population (participants) working on monitoring.
  • Athletes who can measure Recovery speed with a repeatable workout or time-trial effort.

Who should be cautious

  • If you have symptoms or conditions that make the intervention risky, get professional guidance.
  • If you’re near race day and can’t safely test, defer the experiment.

Methods

What the study actually did

  • Design: controlled study.
  • Population: participants.
  • Comparator: comparison group.
  • Outcomes measured: Recovery speed.
  • Protocol cues mentioned: 0.5h.
  • Source: PubMed PMID 39778237 (2025) — Computers in biology and medicine.

Results excerpt

What the abstract reports

The ensemble model exhibited the best performance (AUROC = 0.878), followed closely by XGB algorithm (AUROC = 0.869).

Note: excerpts are short; for full context, read the paper.

Limits

Limitations and bias

  • Abstract-only summaries can miss critical details (population, protocol, adherence, and context).
  • Single studies often don’t generalize to your event, history, and training load; treat results as a starting point.
  • If your context differs (elite vs recreational; cycling vs running), adjust expectations and be conservative.
  • This is performance information, not medical advice.

Adaptive AI coach for iPhone

Meet your adaptive AI coach.

Tell your coach what you are training for. It builds the plan, follows the work you complete, and adapts upcoming training when recovery, your schedule, or real life changes.

Keep going

Sources